Objectives
To determine whether expectations of treatment outcomes in women participating in a drug and behavioral treatment trial for urge urinary incontinence are related to patient factors, demographics, health-related locus of control and treatment outcomes.
Methods
Baseline assessments included expectations (improvement in bladder condition, time to improvement in bladder condition, and duration of improvement) and the multidimensional health locus of control (MHLC) scale. Outcomes were measured by patient global impression of improvement (PGI-I) at the end of active treatment (10 weeks) and 8 months after trial start.
Results
At baseline among 173 subjects, 114 (66%) believed their incontinence would get ‘very much better,’ 94 (55%) expected improvement by one month, and 111 (66%) expected improvement would last the rest of their lives.. There were no significant associations between baseline expectations or MHLC with PGI-I at 10 weeks or 8 months.
Conclusions
Expectations of treatment outcome and MHLC did not predict eventual patient-reported treatment outcome in this sample of women with urge-predominant urinary incontinence participating in a trial of drug and behavioral therapy.